Back to title page |
Structural changes in sulfated carbohydrate chains are abnormalities of biomolecules in many disorders such as cancer and Alzheimerユs disease. At our department, research is carried out to clarify the role of sulfated carbohydrate chains in the body and their association with various disorders.
In animal tissue, there is a group of sulfated carbohydrate chains called glycosaminoglycan, which is present as proteoglycan molecules covalently binding to the core protein and plays various indispensable roles in cell proliferation/differentiation and the formation of tissue morphology. These molecules, also observed on the cell surface, play a role as receptors at the time of infection with viruses and pathogens, and undergo cancerous changes. When a certain type of sulfated carbohydrate chains (heparan sulfate) is not produced, bone cancer develops. In genetic diseases in which heparan sulfate is not produced, abnormalities in intestinal absorption occur, resulting in death immediately after birth. Bone abnormalities and marked intellectual impairment due to abnormal degradation of sulfated carbohydrate chains have long been known. On the other hand, sulfated carbohydrate chains have been suggested to be potential drugs for the treatment of various disorders such as AIDS and cancer. At our department, basic studies on the structure, function, and the control of the biosynthesis and degradation of these carbohydrate chains are performed to clarify the causes of various disorders, develop diagnostic methods, and create new drugs using carbohydrate chains. Briefly, the following projects are underway. 1. Development of methods for early diagnosis using sera obtained from patients with cancer, rheumatism, arthritis, mucopolysaccharidosis, and other genetic diseases.
|